Literature DB >> 17296553

Olig2-regulated lineage-restricted pathway controls replication competence in neural stem cells and malignant glioma.

Keith L Ligon1, Emmanuelle Huillard, Shwetal Mehta, Santosh Kesari, Hongye Liu, John A Alberta, Robert M Bachoo, Michael Kane, David N Louis, Ronald A Depinho, David J Anderson, Charles D Stiles, David H Rowitch.   

Abstract

Recent studies have identified stem cells in brain cancer. However, their relationship to normal CNS progenitors, including dependence on common lineage-restricted pathways, is unclear. We observe expression of the CNS-restricted transcription factor, OLIG2, in human glioma stem and progenitor cells reminiscent of type C transit-amplifying cells in germinal zones of the adult brain. Olig2 function is required for proliferation of neural progenitors and for glioma formation in a genetically relevant murine model. Moreover, we show p21(WAF1/CIP1), a tumor suppressor and inhibitor of stem cell proliferation, is directly repressed by OLIG2 in neural progenitors and gliomas. Our findings identify an Olig2-regulated lineage-restricted pathway critical for proliferation of normal and tumorigenic CNS stem cells.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17296553      PMCID: PMC1810344          DOI: 10.1016/j.neuron.2007.01.009

Source DB:  PubMed          Journal:  Neuron        ISSN: 0896-6273            Impact factor:   17.173


  84 in total

1.  Deregulation of dorsoventral patterning by FGF confers trilineage differentiation capacity on CNS stem cells in vitro.

Authors:  Limor Gabay; Sally Lowell; Lee L Rubin; David J Anderson
Journal:  Neuron       Date:  2003-10-30       Impact factor: 17.173

2.  An analysis of the gene expression program of mammalian neural progenitor cells.

Authors:  F J Livesey; T L Young; C L Cepko
Journal:  Proc Natl Acad Sci U S A       Date:  2004-01-20       Impact factor: 11.205

3.  Origin of oligodendrocytes in the subventricular zone of the adult brain.

Authors:  Bénédicte Menn; Jose Manuel Garcia-Verdugo; Cynthia Yaschine; Oscar Gonzalez-Perez; David Rowitch; Arturo Alvarez-Buylla
Journal:  J Neurosci       Date:  2006-07-26       Impact factor: 6.167

4.  Glioma stem cells promote radioresistance by preferential activation of the DNA damage response.

Authors:  Shideng Bao; Qiulian Wu; Roger E McLendon; Yueling Hao; Qing Shi; Anita B Hjelmeland; Mark W Dewhirst; Darell D Bigner; Jeremy N Rich
Journal:  Nature       Date:  2006-10-18       Impact factor: 49.962

5.  Hematopoietic stem cell quiescence maintained by p21cip1/waf1.

Authors:  T Cheng; N Rodrigues; H Shen; Y Yang; D Dombkowski; M Sykes; D T Scadden
Journal:  Science       Date:  2000-03-10       Impact factor: 47.728

6.  Increasing p16INK4a expression decreases forebrain progenitors and neurogenesis during ageing.

Authors:  Anna V Molofsky; Shalom G Slutsky; Nancy M Joseph; Shenghui He; Ricardo Pardal; Janakiraman Krishnamurthy; Norman E Sharpless; Sean J Morrison
Journal:  Nature       Date:  2006-09-06       Impact factor: 49.962

7.  Transformation from committed progenitor to leukaemia stem cell initiated by MLL-AF9.

Authors:  Andrei V Krivtsov; David Twomey; Zhaohui Feng; Matthew C Stubbs; Yingzi Wang; Joerg Faber; Jason E Levine; Jing Wang; William C Hahn; D Gary Gilliland; Todd R Golub; Scott A Armstrong
Journal:  Nature       Date:  2006-07-16       Impact factor: 49.962

8.  Conserved mechanisms across development and tumorigenesis revealed by a mouse development perspective of human cancers.

Authors:  Alvin T Kho; Qing Zhao; Zhaohui Cai; Atul J Butte; John Y H Kim; Scott L Pomeroy; David H Rowitch; Isaac S Kohane
Journal:  Genes Dev       Date:  2004-03-15       Impact factor: 11.361

9.  Prognostic importance of TLX1 (HOX11) oncogene expression in adults with T-cell acute lymphoblastic leukaemia.

Authors:  Adolfo A Ferrando; Donna S Neuberg; Richard K Dodge; Elisabeth Paietta; Richard A Larson; Peter H Wiernik; Jacob M Rowe; Michael A Caligiuri; Clara D Bloomfield; A Thomas Look
Journal:  Lancet       Date:  2004-02-14       Impact factor: 79.321

10.  Expression of the oligodendroglial lineage-associated markers Olig1 and Olig2 in different types of human gliomas.

Authors:  Akiko Ohnishi; Hirofumi Sawa; Masumi Tsuda; Yutaka Sawamura; Tomoo Itoh; Yoshinobu Iwasaki; Kazuo Nagashima
Journal:  J Neuropathol Exp Neurol       Date:  2003-10       Impact factor: 3.685

View more
  246 in total

Review 1.  Potential therapeutic implications of cancer stem cells in glioblastoma.

Authors:  Lin Cheng; Shideng Bao; Jeremy N Rich
Journal:  Biochem Pharmacol       Date:  2010-05-10       Impact factor: 5.858

2.  CD133+ niches and single cells in glioblastoma have different phenotypes.

Authors:  Karina Christensen; Henrik Daa Schrøder; Bjarne Winther Kristensen
Journal:  J Neurooncol       Date:  2010-12-24       Impact factor: 4.130

3.  Post-translational Modifications of OLIG2 Regulate Glioma Invasion through the TGF-β Pathway.

Authors:  Shiv K Singh; Roberto Fiorelli; Robert Kupp; Sindhu Rajan; Emily Szeto; Costanza Lo Cascio; Cecile L Maire; Yu Sun; John A Alberta; Jennifer M Eschbacher; Keith L Ligon; Michael E Berens; Nader Sanai; Shwetal Mehta
Journal:  Cell Rep       Date:  2016-07-07       Impact factor: 9.423

4.  Glioblastoma-derived epidermal growth factor receptor carboxyl-terminal deletion mutants are transforming and are sensitive to EGFR-directed therapies.

Authors:  Jeonghee Cho; Sandra Pastorino; Qing Zeng; Xiaoyin Xu; William Johnson; Scott Vandenberg; Roel Verhaak; Andrew D Cherniack; Hideo Watanabe; Amit Dutt; Jihyun Kwon; Ying S Chao; Robert C Onofrio; Derek Chiang; Yuki Yuza; Santosh Kesari; Matthew Meyerson
Journal:  Cancer Res       Date:  2011-10-14       Impact factor: 12.701

5.  The LIM-only transcription factor LMO2 determines tumorigenic and angiogenic traits in glioma stem cells.

Authors:  S-H Kim; E-J Kim; M Hitomi; S-Y Oh; X Jin; H-M Jeon; S Beck; X Jin; J-K Kim; C G Park; S-Y Chang; J Yin; T Kim; Y-J Jeon; J Song; Y C Lim; J D Lathia; I Nakano; H Kim
Journal:  Cell Death Differ       Date:  2015-02-27       Impact factor: 15.828

Review 6.  Pediatric low-grade gliomas: how modern biology reshapes the clinical field.

Authors:  Guillaume Bergthold; Pratiti Bandopadhayay; Wenya Linda Bi; Lori Ramkissoon; Charles Stiles; Rosalind A Segal; Rameen Beroukhim; Keith L Ligon; Jacques Grill; Mark W Kieran
Journal:  Biochim Biophys Acta       Date:  2014-02-28

7.  Sorafenib selectively depletes human glioblastoma tumor-initiating cells from primary cultures.

Authors:  Elisa Carra; Federica Barbieri; Daniela Marubbi; Alessandra Pattarozzi; Roberto E Favoni; Tullio Florio; Antonio Daga
Journal:  Cell Cycle       Date:  2013-01-16       Impact factor: 4.534

8.  Specific ablation of Nampt in adult neural stem cells recapitulates their functional defects during aging.

Authors:  Liana R Stein; Shin-ichiro Imai
Journal:  EMBO J       Date:  2014-05-08       Impact factor: 11.598

9.  Pathological analysis of the surgical margins of resected glioblastomas excised using photodynamic visualization with both 5-aminolevulinic acid and fluorescein sodium.

Authors:  Hirohito Yano; Noriyuki Nakayama; Naoyuki Ohe; Kazuhiro Miwa; Jun Shinoda; Toru Iwama
Journal:  J Neurooncol       Date:  2017-04-21       Impact factor: 4.130

10.  Novel HSP90 inhibitor NVP-HSP990 targets cell-cycle regulators to ablate Olig2-positive glioma tumor-initiating cells.

Authors:  Jun Fu; Dimpy Koul; Jun Yao; Shuzhen Wang; Ying Yuan; Howard Colman; Erik P Sulman; Frederick F Lang; W K Alfred Yung
Journal:  Cancer Res       Date:  2013-03-14       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.